Integrative analysis of enrichment and prognostic value of ferroptosis-related genes and pathways in multiple myeloma

被引:7
作者
Su, Qi [1 ]
Li, Qi [2 ]
Zhang, Weimin [2 ]
Li, Bingzong [2 ]
Zhuang, Wenzhuo [1 ]
机构
[1] Soochow Univ, Sch Biol & Basic Med Sci, Dept Cell Biol, Suzhou, Peoples R China
[2] Soochow Univ, Dept Hematol, Affiliated Hosp 2, Suzhou, Peoples R China
关键词
INTERNATIONAL STAGING SYSTEM; PATHOPHYSIOLOGY; METABOLISM; DIAGNOSIS;
D O I
10.1093/carcin/bgac080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our analyses uncovered ferroptosis-related genes and pathways might play critical roles in MM development and progression. Providing a better understanding, ferroptosis process would contribute to elevating the efficiency of multiple treatment strategies. Ferroptosis is a non-apoptotic form of cell death caused by excessive iron exposure. The role played by the ferroptosis-related genes and pathways in multiple myeloma (MM) is poorly understood. Here, we show that the ferroptosis-related pathways might be involved in tumorigenesis and are closely correlated with the prognosis of MM. The ferroptosis suppressor genes are progressively enriched with the progression of plasma cell dyscrasias. Furthermore, high expression of ferroptosis suppressor genes is correlated with high International Staging System and Revised-ISS staging of MM, as well as the poor outcomes of poor outcomes in progression-free survival and overall survival . The ferroptosis driver genes and the ferroptosis suppressor genes have the opposite effects on the progression and prognosis of MM. Moreover, we reveal that ferroptosis-related genes are associated with cytogenetic abnormalities in MM. The ferroptosis-related pathways and genes might impact the osteogenic differentiation of mesenchymal stromal cells in MM patients. A better understanding of the participation of ferroptosis in MM will pave the way for design of new therapies.
引用
收藏
页码:1050 / 1058
页数:9
相关论文
共 39 条
[1]   Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response [J].
Abdallah, Nadine ;
Rajkumar, S. Vincent ;
Greipp, Patricia ;
Kapoor, Prashant ;
Gertz, Morie A. ;
Dispenzieri, Angela ;
Baughn, Linda B. ;
Lacy, Martha Q. ;
Hayman, Suzanne R. ;
Buadi, Francis K. ;
Dingli, David ;
Go, Ronald S. ;
Hwa, Yi L. ;
Fonder, Amie ;
Hobbs, Miriam ;
Lin, Yi ;
Leung, Nelson ;
Kourelis, Taxiarchis ;
Warsame, Rahma ;
Siddiqui, Mustaqeem ;
Lust, John ;
Kyle, Robert A. ;
Bergsagel, Leif ;
Ketterling, Rhett ;
Kumar, Shaji K. .
BLOOD CANCER JOURNAL, 2020, 10 (08)
[2]   Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma [J].
Bordini, J. ;
Galvan, S. ;
Ponzoni, M. ;
Bertilaccio, M. T. S. ;
Chesi, M. ;
Bergsagel, P. L. ;
Camaschella, C. ;
Campanella, A. .
LEUKEMIA, 2017, 31 (04) :967-970
[3]   Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies [J].
Bordini, Jessica ;
Morisi, Federica ;
Cerruti, Fulvia ;
Cascio, Paolo ;
Camaschella, Clara ;
Ghia, Paolo ;
Campanella, Alessandro .
CANCERS, 2020, 12 (04)
[4]   Iron increases the susceptibility of multiple myeloma cells to bortezomib [J].
Campanella, Alessandro ;
Santambrogio, Paolo ;
Fontana, Francesca ;
Frenquelli, Michela ;
Cenci, Simone ;
Marcatti, Magda ;
Sitia, Roberto ;
Tonon, Giovanni ;
Camaschella, Clara .
HAEMATOLOGICA, 2013, 98 (06) :971-979
[5]   Mechanisms of ferroptosis [J].
Cao, Jennifer Yinuo ;
Dixon, Scott J. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (11-12) :2195-2209
[6]   Iron Metabolism in Ferroptosis [J].
Chen, Xin ;
Yu, Chunhua ;
Kang, Rui ;
Tang, Daolin .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
[7]   ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway [J].
Chu, Bo ;
Kon, Ning ;
Chen, Delin ;
Li, Tongyuan ;
Liu, Tong ;
Jiang, Le ;
Song, Shujuan ;
Tavana, Omid ;
Gu, Wei .
NATURE CELL BIOLOGY, 2019, 21 (05) :579-+
[8]   Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death [J].
Dixon, Scott J. ;
Lemberg, Kathryn M. ;
Lamprecht, Michael R. ;
Skouta, Rachid ;
Zaitsev, Eleina M. ;
Gleason, Caroline E. ;
Patel, Darpan N. ;
Bauer, Andras J. ;
Cantley, Alexandra M. ;
Yang, Wan Seok ;
Morrison, Barclay, III ;
Stockwell, Brent R. .
CELL, 2012, 149 (05) :1060-1072
[9]   Multiple myeloma bone disease: pathophysiology of osteoblast inhibition [J].
Giuliani, Nicola ;
Rizzoli, Vittorio ;
Roodman, G. David .
BLOOD, 2006, 108 (13) :3992-3996
[10]   International staging system for multiple myeloma [J].
Greipp, PR ;
San Miguel, J ;
Durie, BGM ;
Crowley, JJ ;
Barlogie, B ;
Bladé, J ;
Boccadoro, M ;
Child, JA ;
Harousseau, JL ;
Kyle, RA ;
Lahuerta, JJ ;
Ludwig, H ;
Morgan, G ;
Powles, R ;
Shimizu, K ;
Shustik, C ;
Sonneveld, P ;
Tosi, P ;
Turesson, I ;
Westin, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3412-3420